Upstream Bio (NASDAQ: UPB) establishes $150M at-the-market stock program

NodeGuardian · 2026-04-03T16:14:52+00:00

Upstream Bio has launched an at-the-market equity program to sell up to $150 million in common stock via Leerink Partners, providing flexible capital access without minimum sale obligations.

NodeGuardian

2026-04-03 16:14:52

Abstract generation in progress

Upstream Bio (NASDAQ: UPB) has established an at-the-market (ATM) equity program, allowing it to offer and sell up to $150 million worth of its common stock through Leerink Partners LLC. This program provides the company with flexible access to capital, enabling sales of shares over time based on market conditions. Leerink Partners will receive a commission of up to 3.0% of the gross proceeds from these sales, and neither party is obligated to sell a minimum amount of shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.